| | Variaz. | Variaz. 5g. | Variaz. 1 gen. | Variaz. 1anno | Variaz. 3anni | Capi. (M$) |
 | ARBUTUS BIOPHARMA CORPORATION | 3.32% | -1.41% | -28.02% | -10.54% | 23.89% | 416 |
| | | | | | | |
 | CSL LIMITED | 0.06% | -0.74% | -7.39% | -5.03% | 24.32% | 88 033 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -1.14% | -3.10% | -13.51% | -8.65% | 143.30% | 42 746 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -1.17% | 2.64% | -22.42% | -49.54% | 207.06% | 38 608 |
| BIOGEN INC. | 3.28% | -0.61% | -12.21% | -39.63% | -10.56% | 30 847 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | 2.66% | 4.60% | -8.54% | -39.94% | 156.38% | 27 210 |
 | UCB | 2.43% | 2.05% | -17.69% | -7.79% | 11.53% | 16 253 |
| BIOMARIN PHARMACEUTICAL INC. | 2.55% | -2.15% | -3.81% | 1.28% | 0.99% | 15 721 |
| WALVAX BIOTECHNOLOGY CO., LTD. | 0.33% | 0.52% | -13.61% | -19.29% | 58.76% | 11 604 |
 | GRIFOLS, S.A. | 3.33% | 0.57% | 10.43% | -17.10% | -28.77% | 11 311 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | -1.93% | -1.11% | -10.22% | -53.37% | --.--% | 10 010 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | -0.94% | -2.99% | -27.16% | -34.50% | 41.30% | 8 817 |
| CELLTRION HEALTHCARE CO., LTD. | 1.31% | 1.46% | -13.34% | -38.78% | 28.68% | 8 290 |
| SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD. | -1.17% | 2.41% | -27.50% | -52.42% | 29.75% | 7 466 |
| INNOVENT BIOLOGICS, INC. | 2.50% | 8.05% | -27.67% | -61.46% | 32.45% | 6 524 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | 0.36% | 2.16% | 19.94% | 40.86% | 20.55% | 6 336 |
| | | | | | | |
| | Media | 0.83% | 0.92% | -11.65% | -25.69% | 51.13% | |
| | Media ponderata per Capi. | 0.60% | 0.25% | -11.53% | -21.99% | 68.54% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
